Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

reflecting the impact of the return to Teva at the end of 2010 of sales generated in the UK and in some Eastern European countries.  

Net sales of Xyzal® in the U.S. were euro 3 million, down 90.1% due to generic competition.

(1) See Appendix 9 for definitions of financial indicators

Consumer Health CareFirst-quarter sales of the Consumer Health Care (CHC) business were euro 712 million, an increase of 40.3%. This strong performance reflected dynamic organic growth (+23.0% on a constant structure basis and at constant exchange rates) and includes sales of Allegra® OTC which was successfully launched by Chattem in the U.S. in the first quarter and reached sales of euro 80 million.

CHC sales in Emerging markets grew by 30.3% to euro 301 million. At the end of the quarter, the Group completed the acquisition of BMP Sunstone.

GenericsFirst-quarter net sales for the generics business were euro 414 million, up 16.9% led by Emerging Markets and the U.S. where the Group launched authorized generics of Ambien®CR (sales of euro 12 million for Zolpidem/Zolpidem CR) and Taxotere® (sales euro 12 million). Sales in Emerging Markets grew by 23.4% (euro 258 million) over the period and showed strong organic growth in Latin America as well as in Russia supported by the recent acquisitions of Medley in Brazil and Zentiva in Eastern Europe.

Human Vaccines First-quarter consolidated net sales for the Human Vaccines business were euro 602 million, an increase of 9.6% excluding A/H1N1 influenza vaccine sales booked in the first quarter of 2010, or a decline of 38.3% including A/H1N1 vaccines sales. In Emerging Markets, sales grew 37.1% (euro 277 million) excluding A/H1N1 sales.

Seasonal influenza vaccine net sales in the first quarter were euro 101 million, up 175.5%, reflecting dynamic demand in the Southern hemisphere and an earlier delivery compared to 2010. The fi
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015  Amgen (NASDAQ: AMGN ... full year 2014 financial results on Tuesday, Jan. 27, 2015, after ... followed by a conference call with the investment community at 2 ... Robert A. Bradway , chairman and chief executive officer, and other ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... SEATTLE, Oct. 31, 2011 AquaLiv Technologies (OTCBB: AQLV) ... for their NatuRx™ HIV/AIDS treatment. The company ... HIV/AIDS as an alternative medicine treatment and that approval ... "The process isn,t quite as simple as it was ...
... 2011 At the American Society of ... Institute, LLC (RRI) is presenting research results from studies involving ... advancing therapy options for dialysis patients to provide the highest ... Week 2011 takes place Nov. 8-13 in Philadelphia, PA. It ...
Cached Medicine Technology:AquaLiv Technologies Subsidiary AquaLiv, Inc. Discusses Registration In Kenya Concerning Its HIV/AIDS Treatment 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Va., May 16 CEL-SCI CORPORATION,(Amex: CVM ) ... ended,March 31, 2008., Geert Kersten, Chief Executive Officer ... our cancer therapy Multikine(R) into its,pivotal Phase III clinical ... until the completion of our dedicated manufacturing facility for,Multikine ...
... this morning, Atomic,Energy of Canada Ltd. (AECL) announced ... at Chalk River, but remains committed to providing,ongoing ... leading provider of products and services to the ... about this decision, and,the company is evaluating these ...
... be a key to decreasing the spread of cancer ... research at Washington University School of Medicine in St. ... spread, or metastasis, of breast cancer. Scientists here found ... also received a bone strengthening drug were less likely ...
... and U.S. will discuss quality in health care ... following is being,issued by the German Embassy:, ... a few months away,comprehensive health care coverage for ... Rising costs put pressure on individual citizens, employers,insurance ...
... Move More and Milk ... Their Diets, OMAHA, Neb., May ... different fad diets -- which seem to go in and out of,fashion like ... Americans -- including 25 percent of Nebraska,residents -- remain overweight or obese., ...
... Less than a week after,committing medical relief efforts ... Project HOPE, an international health education and,humanitarian assistance ... to meet the urgent medical needs for the ... which has claimed over,20,000 lives., "I am ...
Cached Medicine News:Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 2Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 3Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 4Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 5Health News:Bone drug could help prevent the spread of breast cancer 2Health News:The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Medicine Products: